|
|
| Company | Total | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
|
Merck Sharp & Dohme Corporation |
$87,240 |
$20,857 |
$28,851 |
$21,031 |
$2,250 |
$14,250 |
$0 |
$0 |
|
PFIZER INC. |
$48,821 |
$6,030 |
$14,710 |
$27,653 |
$429 |
$0 |
$0 |
$0 |
|
Merck Sharp & Dohme LLC |
$38,596 |
$0 |
$0 |
$0 |
$0 |
$0 |
$22,145 |
$16,451 |
|
Exelixis Inc. |
$31,948 |
$7,573 |
$173 |
$398 |
$14,382 |
$272 |
$8,880 |
$269 |
|
E.R. Squibb & Sons, L.L.C. |
$27,081 |
$12,574 |
$3,114 |
$4,808 |
$1,210 |
$2,275 |
$1,747 |
$1,355 |
|
|
|
|
|
|
|
|
|
|
| Clinical Trial | Tweets | Peer Outreach | Peer Engagement |
| CHECKMATE 816 | 1 | 0 | 16 |
| KEYNOTE-671 | 1 | 0 | 15 |
| KEYNOTE-671 | 1 | 0 | 15 |
| MRD | 0 | 1 | 0 |
| CHECKMATE 914 | 0 | 5 | 0 |